figshare
Browse
irab_a_1969050_sm3753.docx (224.77 kB)

Identification of odor biomarkers in irradiation injury urine based on headspace SPME-GC-MS

Download (224.77 kB)
Version 2 2021-08-31, 20:20
Version 1 2021-08-17, 14:40
journal contribution
posted on 2021-08-31, 20:20 authored by Xin Wu, Tong Zhu, Hongbing Zhang, Lu Lu, Xin He, Changxiao Liu, Sai-jun Fan

The threat of population exposure to ionizing radiation is increasing rapidly worldwide. Such exposure, especially at high-dose, is known to cause acute radiation syndrome (ARS). Hence, it is necessary to develop specific and sensitive biomarkers to accurately diagnose radiation injury and evaluate medical countermeasures.

Caenorhabditis elegans (C. elegans), a model organism with a fine and sound olfactory system, was used to examine the odor of urine samples collected from irradiation-injured rats, and compared with those from un-irradiated control rats to investigate the ‘special odor’ of radiation injury. Subsequently, headspace SPME-GC-MS was applied for non-targeted metabolomic analysis of volatile organic compounds (VOCs) in urine, with the aim to discover changes of small molecule metabolites and identify odor biomarkers of irradiation injury.

C. elegans showed significant attraction to the urine of total body irradiation (TBI) rats compared with control rats, indicating that irradiation injury can emit ‘special odor’ and the metabolites in urine VOCs were changed. Using metabolomics based on headspace SPME-GC-MS for metabolic profiles analysis, we screened 63 differentially expressed metabolites. Among them, 10 metabolites including p-Cresol with excellent diagnostic ability were identified as odor biomarkers according to receiver operating characteristic (ROC) curve analysis.

This study confirmed the ‘special odor’ induced by irradiation injury, and identified biomarkers through urine VOCs analysis for the first time, which can provide a novel approach and insight to evaluate irradiation injury noninvasively, accurately and conveniently.

Funding

This work was supported by the grants from the National Natural Science Foundation of China [No. 81730086], the Drug Innovation Major Projects of China [No. 2018ZX09711001-007-008], the CAMS Innovation Fund for Medical Sciences [No. 2016-I2M-1-017 and 2017-I2M-B&R-13] and the Fundamental Research Funds for the Central Universities [No. 3332019098].

History